The University of Chicago Medical Center - Hyde Park - Hematology & Oncology is a clinical research site located in Chicago, Illinois, United States 60637.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Advanced Solid Tumors, Advanced Non-small Cell Lung Cancer, HER2 Mutation.
Sponsors: Bayer.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology has 3 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Advanced Non-small Cell Lung Cancer, HER2 Mutation.
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.